share_log

Nxu Inc | S-1: General form for registration of securities under the Securities Act of 1933

Nxu Inc | S-1: General form for registration of securities under the Securities Act of 1933

Nxu Inc | S-1：证券上市注册声明
美股SEC公告 ·  2024/12/31 05:15

Moomoo AI 已提取核心信息

Nxu Inc. has filed to register up to 114,503,816 shares of Class A common stock for resale by selling stockholders. The shares include 6.8 million purchased shares and 107.7 million shares issuable upon exercise of warrants issued in a $3 million private placement on December 26, 2024.The company issued pre-funded warrants for 5.2 million shares, Series A warrants for up to 57.25 million shares, and Series B warrants for up to 45.25 million shares. The pre-funded warrants have a $0.0001 exercise price, Series A warrants $0.50, and Series B warrants $0.0001. Nxu will not receive proceeds from the resale but may receive proceeds if warrants are exercised.The filing also discloses Nxu's pending merger with Verde Bioresins, where Verde shareholders would own 95% of the combined company. Nxu had $2.2 million cash as of September 30, 2024 and warns of substantial doubt about its ability to continue as a going concern without additional funding.
Nxu Inc. has filed to register up to 114,503,816 shares of Class A common stock for resale by selling stockholders. The shares include 6.8 million purchased shares and 107.7 million shares issuable upon exercise of warrants issued in a $3 million private placement on December 26, 2024.The company issued pre-funded warrants for 5.2 million shares, Series A warrants for up to 57.25 million shares, and Series B warrants for up to 45.25 million shares. The pre-funded warrants have a $0.0001 exercise price, Series A warrants $0.50, and Series B warrants $0.0001. Nxu will not receive proceeds from the resale but may receive proceeds if warrants are exercised.The filing also discloses Nxu's pending merger with Verde Bioresins, where Verde shareholders would own 95% of the combined company. Nxu had $2.2 million cash as of September 30, 2024 and warns of substantial doubt about its ability to continue as a going concern without additional funding.
Nxu Inc. 已申请注册高达114,503,816股A类普通股，以供出售股东转售。这些股份包括680万购入的股份和10770万在2024年12月26日进行的300万美元定向增发中发行的可行权股份。该公司发行了520万股预先融资Warrants，最多5725万股A系列Warrants和最多4525万股B系列Warrants。预先融资Warrants的行使价格为0.0001美元，A系列Warrants为0.50美元，B系列Warrants为0.0001美元。Nxu不会从转售中获得收益，但如果Warrants被行使，可能会获得收益。该文件还披露了Nxu与Verde Bioresins的待合并事宜，其中Verde的股东将拥有合并后公司95%的股份。截至2024年9月30日，Nxu拥有220万美元现金，并警告其在没有额外资金支持的情况下持续运营的能力存在重大疑虑。
Nxu Inc. 已申请注册高达114,503,816股A类普通股，以供出售股东转售。这些股份包括680万购入的股份和10770万在2024年12月26日进行的300万美元定向增发中发行的可行权股份。该公司发行了520万股预先融资Warrants，最多5725万股A系列Warrants和最多4525万股B系列Warrants。预先融资Warrants的行使价格为0.0001美元，A系列Warrants为0.50美元，B系列Warrants为0.0001美元。Nxu不会从转售中获得收益，但如果Warrants被行使，可能会获得收益。该文件还披露了Nxu与Verde Bioresins的待合并事宜，其中Verde的股东将拥有合并后公司95%的股份。截至2024年9月30日，Nxu拥有220万美元现金，并警告其在没有额外资金支持的情况下持续运营的能力存在重大疑虑。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

独立文件6  查看翻译

独立文件7  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间